Overview of the Mental Health of Adolescents in Therapeutci, Educational and Pedagogical Facilities in France (PsyPreDi)

Etat Des Lieux de la santé Mentale Des Adolescents Suivis Par Les Dispositifs ITEP en France

Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes.

Study Overview

• Status: Recruiting
• Conditions: Mental Health Disorder
• Intervention / Treatment: Diagnostic test: WAIS IV

• Study Type: Observational
• Enrollment (Estimated): 200

Contacts and Locations

• Study Contact: Name: Priscille Gerardin, Pr; Phone Number: 02.32.88.56.96; Email: priscille.gerardin@chu-roue.fr

Study Locations

• France
  • Besançon, France
    • Recruiting
    • CHU Bourgogne Franche Comté
    • Contact: Lauriane VUILLIEZ; Phone Number: 0232888990; Email: cecile.pourcher@chu-rouen.fr
  • Rouen, France
    • Recruiting
    • CHU Rouen
    • Contact: Priscille GERARDIN; Phone Number: +33 0232888990; Email: cecile.pourcher@chu-rouen.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

This is a prospective, multicentric, national cohort, including adolescents aged 12 to 16 consecutively, who have been in a French-speaking, voluntary DITEP for at least 15 days, and whose parents have given their consent.

This choice was motivated by the fact that this is the age group most represented in Therapeutic, Educatuional and Pedagogical Institutes

Description

Inclusion Criteria:

• Adolescent aged 12 to 16
• In a DITEP for at least 15 days
• Minor who has been informed and has not objected to the research (according to his/her capacity)
• At least one person exercising parental authority who has read and understood the information note and has not objected to the research OR
• For a minor under guardianship: legal representative who has read and understood the information note and has not objected to the research.

Exclusion Criteria:

• Minor and/or person(s) exercising parental authority who do not understand French
• Holder of parental authority opposed to the search
• Minor opposed to search

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Presence of psychiatric disorders	assessed according to DSM-5 by K- SADS-PL	Inclusion
nature of psychiatric disorders	assessed according to DSM-5 by K- SADS-PL	Inclusion

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Describe the psychological characteristics of adolescents aged 12 to 16	Traumatisms	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Attachement	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Toronto Alexithymia Scale	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Empathy scale	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Impulsivity scale	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Reflective self esteem scale	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Abbreviated-diagnostic interview for borderlines	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Hostility	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Buss Durkee Hostility Inventory	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Mentoring assessed by Reflective Functioning Questionnaire	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Coping strategies assessed by Adolescent Coping Scale	Inclusion
Describe the psychological characteristics of adolescents aged 12 to 16	Risk behaviour assessed by COLUMBIA-SUICIDE SEVERITY RATING SCALE	Inclusion
cognitive abilities	Raven's Matrix	Inclusion
Adverse exepriences	Adverse Child Experiences	Inclusion

Collaborators and Investigators

• Sponsor: University Hospital, Rouen

Study record dates

Study Major Dates

• Study Start (Actual): December 20, 2024
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026

Study Registration Dates

• First Submitted: June 28, 2024
• First Submitted That Met QC Criteria: June 28, 2024
• First Posted (Actual): July 8, 2024

Study Record Updates

• Last Update Posted (Actual): June 10, 2026
• Last Update Submitted That Met QC Criteria: June 8, 2026
• Last Verified: June 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders
• Other Study ID Numbers: 2022/0282/OB

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No